Dr. Albert “Gus” Davis Connects Sleep, Epilepsy, and Circadian Science at ANA2025
Dr. Albert “Gus” Davis presents Observations from the NAPS Consortium for REM Sleep Behavior at ANA2025.
The NAPS Consortium is leading the way in understanding REM sleep behavior disorder, a key prodromal stage of synucleinopathies.
Dr. Albert “Gus” Davis joined experts in sleep, epilepsy, and circadian medicine for an engaging session exploring how these systems intertwine to influence neurological health at ANA2025.
💡 Key takeaways:
• Sleep can both affect and trigger seizures, with some epilepsy syndromes closely linked to sleep patterns.
• The NAPS Consortium shared insights into REM Sleep Behavior Disorder (RBD) as a prodromal stage of synucleinopathies, highlighting biomarkers that may guide disease-modifying therapies.
• Circadian Medicine is shaping the future of neurology, using the body’s biological clock as both a diagnostic tool and therapeutic target.
The session underscored how understanding sleep and circadian systems can illuminate new pathways for early detection and treatment across neurological disorders.
